BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6391067)

  • 1. Spasmodic torticollis: treatment with Tizanidine.
    ten Houten R; Lakke JP; de Jong P; van Weerden TW; van den Burg W; Wesseling H
    Acta Neurol Scand; 1984 Nov; 70(5):373-6. PubMed ID: 6391067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine treatment of spasmodic torticollis. A double-blind crossover study.
    Juntunen J; Kaste M; Iivanainen M; Ranta T; Seppälä M
    Arch Neurol; 1979 Jul; 36(7):449-50. PubMed ID: 378199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis.
    Greene P; Kang U; Fahn S; Brin M; Moskowitz C; Flaster E
    Neurology; 1990 Aug; 40(8):1213-8. PubMed ID: 2199847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety.
    Vakhapova V; Auriel E; Karni A
    Clin Neuropharmacol; 2010 May; 33(3):151-4. PubMed ID: 20502134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study.
    Fogelholm R; Murros K
    Headache; 1992 Nov; 32(10):509-13. PubMed ID: 1468911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.
    Poewe W; Burbaud P; Castelnovo G; Jost WH; Ceballos-Baumann AO; Banach M; Potulska-Chromik A; Ferreira JJ; Bihari K; Ehler E; Bares M; Dzyak LA; Belova AN; Pham E; Liu WJ; Picaut P
    Mov Disord; 2016 Nov; 31(11):1649-1657. PubMed ID: 27653448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients.
    Lorentz IT; Subramaniam SS; Yiannikas C
    Mov Disord; 1991; 6(2):145-50. PubMed ID: 2057005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tizanidine in the treatment of spasticity.
    Newman PM; Nogues M; Newman PK; Weightman D; Hudgson P
    Eur J Clin Pharmacol; 1982; 23(1):31-5. PubMed ID: 6751834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of buspirone and verapamil to improve spasmodic torticollis.
    Naber D; Weinberger DR; Gillespie M; Chase TN
    J Neuropsychiatry Clin Neurosci; 1992; 4(1):82-4. PubMed ID: 1627968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia.
    Bes A; Eyssette M; Pierrot-Deseilligny E; Rohmer F; Warter JM
    Curr Med Res Opin; 1988; 10(10):709-18. PubMed ID: 3286129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain.
    Berry H; Hutchinson DR
    J Int Med Res; 1988; 16(2):75-82. PubMed ID: 2967780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tizanidine (DS 103-282) in the treatment of acute paravertebral muscle spasm: a controlled trial comparing tizanidine and diazepam.
    Fryda-Kaurimsky Z; Müller-Fassbender H
    J Int Med Res; 1981; 9(6):501-5. PubMed ID: 6459256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lisuride in generalised dystonia and spasmodic torticollis.
    Bassi S; Ferrarese C; Frattola L; Sbacchi M; Trabucchi M
    Lancet; 1982 Feb; 1(8270):514-5. PubMed ID: 6121171
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin in spasmodic torticollis.
    Tsui JK; Eisen A; Calne DB
    Adv Neurol; 1988; 50():593-7. PubMed ID: 3400512
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C; Muff S; Smolenski-Kautz S
    Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind trial of botulinum toxin "A" in torticollis, with one year follow up.
    Moore AP; Blumhardt LD
    J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):813-6. PubMed ID: 1955900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
    Smith C; Birnbaum G; Carter JL; Greenstein J; Lublin FD
    Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind study of botulinum toxin in spasmodic torticollis.
    Tsui JK; Eisen A; Stoessl AJ; Calne S; Calne DB
    Lancet; 1986 Aug; 2(8501):245-7. PubMed ID: 2874278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tizanidine and ibuprofen in acute low-back pain: results of a double-blind multicentre study in general practice.
    Berry H; Hutchinson DR
    J Int Med Res; 1988; 16(2):83-91. PubMed ID: 2967781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.